Search Results for: TCF4

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
TLE3 TLE family member 3, transcriptional corepressor
  • Formation of the beta-catenin:TCF transactivating complex
  • Deactivation of the beta-catenin transactivating complex
  • Repression of WNT target genes
  • Repression of WNT target genes
  • Estrogen-dependent gene expression
TLE5 TLE family member 5, transcriptional modulator
  • Repression of WNT target genes
TMEM213 transmembrane protein 213
TP53 tumor protein p53
  • Activation of NOXA and translocation to mitochondria
  • Activation of PUMA and translocation to mitochondria
  • Pre-NOTCH Transcription and Translation
  • Oxidative Stress Induced Senescence
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Oncogene Induced Senescence
  • DNA Damage/Telomere Stress Induced Senescence
  • SUMOylation of transcription factors
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Association of TriC/CCT with target proteins during biosynthesis
  • Pyroptosis
  • TP53 Regulates Metabolic Genes
  • Ub-specific processing proteases
  • Ovarian tumor domain proteases
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Interleukin-4 and Interleukin-13 signaling
  • TP53 Regulates Transcription of DNA Repair Genes
  • TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
  • TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
  • TP53 Regulates Transcription of Caspase Activators and Caspases
  • TP53 Regulates Transcription of Death Receptors and Ligands
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
  • TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
  • Regulation of TP53 Expression
  • Regulation of TP53 Activity through Phosphorylation
  • Regulation of TP53 Degradation
  • Regulation of TP53 Activity through Acetylation
  • Regulation of TP53 Activity through Association with Co-factors
  • Regulation of TP53 Activity through Methylation
  • PI5P Regulates TP53 Acetylation
  • G2/M DNA damage checkpoint
  • G2/M Checkpoints
  • Stabilization of p53
  • Transcriptional activation of cell cycle inhibitor p21
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • Transcriptional Regulation by VENTX
  • RUNX3 regulates CDKN1A transcription
  • Regulation of PTEN gene transcription
  • Regulation of PTEN gene transcription
  • Loss of function of TP53 in cancer due to loss of tetramerization ability
  • Signaling by ALK fusions and activated point mutants
  • Regulation of NF-kappa B signaling
  • Zygotic genome activation (ZGA)
  • Factors involved in megakaryocyte development and platelet production
  • PKR-mediated signaling
  • Acetylsalicylic acid
  • Zinc
  • Triethyl phosphate
  • AZD 3355
  • 1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Chronic myeloid leukemia (CML)
  • Breast cancer
  • Non-small cell lung cancer
  • Gastric cancer
  • Adult T-cell leukemia
  • Choriocarcinoma
  • Esophageal cancer
  • Glioma
  • Pancreatic cancer
  • Vulvar cancer
  • Multiple myeloma
  • Choroid plexus papilloma
  • Ovarian cancer
  • Hepatocellular carcinoma
  • Squamous cell carcinoma
  • Endometrial Cancer
  • Penile cancer
  • Cancer of the anal canal
  • Hairy-cell leukemia
  • Oral cancer
  • Adrenal carcinoma
  • Malignant melanoma
  • Burkitt lymphoma
  • Thyroid cancer
  • Basal cell carcinoma
  • Small cell lung cancer
  • Gallbladder cancer
  • Bladder cancer
  • Laryngeal cancer
  • Kaposi's sarcoma
  • Cholangiocarcinoma
  • Chronic lymphocytic leukemia (CLL)
  • Li-Fraumeni syndrome, including: Classic Li-Fraumeni syndrome (LFS); LFS-like syndrome (LFSL)
  • Malignant pleural mesothelioma
  • Osteosarcoma
  • Colorectal cancer
TRAPPC2L trafficking protein particle complex subunit 2L
  • COPII-mediated vesicle transport
  • RAB GEFs exchange GTP for GDP on RABs
TRIM68 tripartite motif containing 68
  • Interferon gamma signaling
TRIML2 tripartite motif family like 2
TSPOAP1 TSPO associated protein 1
  • Serotonin Neurotransmitter Release Cycle
  • Norepinephrine Neurotransmitter Release Cycle
  • Pregnenolone biosynthesis
  • Glutamate Neurotransmitter Release Cycle
  • Dopamine Neurotransmitter Release Cycle
  • Acetylcholine Neurotransmitter Release Cycle
TSSC4 tumor suppressing subtransferable candidate 4
TSSK3 testis specific serine kinase 3
TSTD2 thiosulfate sulfurtransferase like domain containing 2
TTF2 transcription termination factor 2
TWIST1 twist family bHLH transcription factor 1
  • Interleukin-4 and Interleukin-13 signaling
  • Transcriptional regulation by RUNX2
  • Regulation of RUNX2 expression and activity
  • Regulation of RUNX2 expression and activity
  • Nuclear events stimulated by ALK signaling in cancer
  • Negative Regulation of CDH1 Gene Transcription
  • Craniosynostosis, including: Pfeiffer syndrome; Apert syndrome; Crouzon syndrome; Jackson-Weiss syndrome; Beare-Stevenson syndrome; Muenke craniosynostosis; Saethre-Chotzen syndrome; Craniosynostosis Boston type; Antley-Bixler syndrome; Carpenter syndrome; Craniofrontonasal dysplasia; Noonan syndrome; Baller-Gerold syndrome
TWIST2 twist family bHLH transcription factor 2
  • Transcriptional regulation by RUNX2
  • Negative Regulation of CDH1 Gene Transcription
TXNL4B thioredoxin like 4B
UBASH3B ubiquitin associated and SH3 domain containing B
UBE2I ubiquitin conjugating enzyme E2 I
  • Meiotic synapsis
  • Vitamin D (calciferol) metabolism
  • SUMO is transferred from E1 to E2 (UBE2I, UBC9)
  • SUMO is transferred from E1 to E2 (UBE2I, UBC9)
  • SUMOylation of DNA damage response and repair proteins
  • SUMOylation of transcription factors
  • SUMOylation of transcription factors
  • SUMOylation of ubiquitinylation proteins
  • SUMOylation of transcription cofactors
  • SUMOylation of transcription cofactors
  • SUMOylation of SUMOylation proteins
  • SUMOylation of intracellular receptors
  • SUMOylation of intracellular receptors
  • SUMOylation of chromatin organization proteins
  • SUMOylation of chromatin organization proteins
  • SUMOylation of RNA binding proteins
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA methylation proteins
  • SUMOylation of DNA methylation proteins
  • SUMOylation of immune response proteins
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Processing of DNA double-strand break ends
  • Formation of Incision Complex in GG-NER
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • Postmitotic nuclear pore complex (NPC) reformation
  • Maturation of nucleoprotein
  • Maturation of nucleoprotein
  • SARS-CoV-1 targets host intracellular signalling and regulatory pathways
  • SUMOylation of nuclear envelope proteins
  • PKR-mediated signaling
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
  • Transcriptional and post-translational regulation of MITF-M expression and activity
UTP23 UTP23 small subunit processome component
VPS28 VPS28 subunit of ESCRT-I
  • Budding and maturation of HIV virion
  • Membrane binding and targetting of GAG proteins
  • Endosomal Sorting Complex Required For Transport (ESCRT)
  • HCMV Late Events
  • Late endosomal microautophagy
XRCC5 X-ray repair cross complementing 5
  • 2-LTR circle formation
  • Cytosolic sensors of pathogen-associated DNA
  • IRF3-mediated induction of type I IFN
  • Nonhomologous End-Joining (NHEJ)
  • Neutrophil degranulation

Page 11 out of 12 pages